Mostrando 10 resultados de: 10
Filtros aplicados
Publisher
Arthritis Care and Research(1)
Autoimmunity Reviews(1)
Biologics: Targets and Therapy(1)
Clinical Reviews in Allergy and Immunology(1)
Clinical Rheumatology(1)
Clinical pbkp_redictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
ArticleAbstract: Objectives: To identify baseline pbkp_redictors of remission and low disease activity (LDA) in earlyPalabras claves:Early RA outcomes, Early RA remission, Early RA response pbkp_redictors, Latin America early RAAutores:Achurra-Castillo A.F., Alarcón G.S., Andrade-Ortega L., Appenzeller S., Ballesteros F., Barile-Fabris L.A., Bianchi W.A., Caballero-Uribe C.V., Cardiel M.H., Castelar-Pinheiro G.d.R., Claudio M. Galarza-Maldonado, Da Silveira I.G., de Freitas Zerbini C.A., Esquivel-Valerio J.A., Esteva-Spinetti M.H., Gamboa-Cárdenas R.V., García de la Torre I., Guibert-Toledano M., Loreto M., Monge P., Montufar R.A., Palezuelos F.I., Pisoni C.N., Pons-Estel B.A., Radominski S.C., Rios C., Rojas-Villarraga A., Sacnun M.P., Saurit V., Soriano E.R., Teijeiro R., Ugarte-Gil M.F., Vazquez-Mellado J.Fuentes:scopusDiagnosis and classification of rheumatoid arthritis
ArticleAbstract: Rheumatoid arthritis (RA) is a systemic chronic inflammatory disease of unclear etiology that is manPalabras claves:Anti-cyclic citrullinated peptide (anti-CCP), Classification criteria, Rheumatoid Arthritis, Rheumatoid factorAutores:Claudio M. Galarza-Maldonado, Esteban Ortiz-Prado, Kourilovitch M.R.Fuentes:scopusEarly rheumatoid arthritis in Latin America: Low socioeconomic status related to high disease activity at baseline
ArticleAbstract: Objective To determine the influence of socioeconomic factors on disease activity in a Latin AmericaPalabras claves:Autores:Acevedo-Vásquez E.M., Achurra-Castillo A.F., Caballero-Uribe C.V., Cardiel M.H., Claudio M. Galarza-Maldonado, Díaz-Coto J.F., Esteva-Spinetti M.H., Furst D.E., Guibert-Toledano Z.M., Hernández J.A., Laurindo I.M., Lino-Pérez L., Massardo L., Montufar R.A., Mota L.M.H., Padilla O., Pineda-Villaseñor C., Pons-Estel B.A., Ramírez L.A., Sacnun M.P., Soriano E.R., Wojdyla D.Fuentes:scopusNeurological manifestations of systemic lupus erythematosus: A comprehensive literature review
ReviewAbstract: Among autoimmune diseases, systemic lupus erythematosus (SLE) stands out. This disease is characteriPalabras claves:CNS, Neurologic complications, SLEAutores:Andrés López-Cortés, Claudio M. Galarza-Maldonado, Dayana Cuchiparte, Esteban Ortiz-Prado, Jorge Eduardo Vásconez, Katherine Peláez, Luis Leonardo Cano Cevallos, María Belén-LópezFuentes:googlescopusInfections and the antiphospholipid syndrome
ReviewAbstract: Currently, the origin of autoimmune diseases is considered to be multifactorial. Genetic pbkp_redispPalabras claves:Anticardiolipin, Antiphospholipid, infection, ThrombosisAutores:Cervera R., Claudio M. Galarza-Maldonado, Escárcega R.O., García-Carrasco M., Mendoza-Pinto C.Fuentes:scopusMesenterial thrombosis with the antiphospholipid syndrome
ArticleAbstract:Palabras claves:Autores:Claudio M. Galarza-Maldonado, Serrano-Alvarado P.Fuentes:scopusIs Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
ArticleAbstract: Purpose: Tofacitinib is recommended for treatment of rheumatoid arthritis (RA) in patients with modePalabras claves:biologics, Rheumatoid Arthritis, tofacitinib, TreatmentAutores:Claudio M. Galarza-Maldonado, Ibata L., Martinez S., Rivero M., Rodríguez-Florido F., Rojas-Villarraga A., Santos-Moreno P., Villarreal L.Fuentes:scopusTreating obstetric antiphospholipid syndrome
ReviewAbstract: Systemic autoimmune thrombosis or antiphospholipid syndrome is a treatable cause of miscarriages andPalabras claves:antiphospholipid antibodies, Antiphospholipid syndrome, aspirin, heparin, miscarriages, spontaneous abortions, ThrombosisAutores:Andrade-Sánchez P., Claudio M. Galarza-Maldonado, Elisa Asanza, Kourilovitch M.R., María C. DuránFuentes:scopusReport on the second PANLAR review course in rheumatology: Biosimilars update
ArticleAbstract:Palabras claves:Autores:Azevedo V.F., Caballero-Uribe C.V., Claudio M. Galarza-Maldonado, Jimenez O.C., Kos I.A., Pineda-Villaseñor C., Soriano E.R.Fuentes:scopusThe administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus
ReviewAbstract: Background: In Latin America, the medical attention directed to systemic autoimmune diseases competePalabras claves:Autores:Cardiel M.H., Cervera R., Claudio M. Galarza-Maldonado, Doukh N., Kourilovitch M.R., Molineros J.E., Soroka N.F., Yagur V.Y., Zurita L.Fuentes:scopus